Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer
- 1 November 1983
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 19 (11), 1615-1624
- https://doi.org/10.1016/0277-5379(83)90094-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.BMJ, 1983
- Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer. A randomized trial of the piedmont oncology associationCancer, 1982
- The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancerBreast Cancer Research and Treatment, 1981
- Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapyCancer, 1980
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1980
- Combined cytotoxic and progestogen therapy for advanced breast cancerCancer, 1978
- Combined chemo- and hormonal therapy in advanced breast cancerCancer, 1977
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958